Were Hedge Funds Right About Dumping Incyte Corporation (INCY)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750......(read more)
Posts Tagged ‘NASDAQ:INCY’
Here’s What Hedge Funds Think About Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company......(read more)
Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due......(read more)
Is Incyte Corporation (INCY) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
Insider Buying Roundup: Elon Musk Buys Tesla (TSLA) Shares After Earnings Call Backlash
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares......(read more)
Wondering What’s Happening in the Financial Markets Today? Take a Look at These 34 Stories!
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty......(read more)
What’s Going On In The Finance World Today?
1. US Stock Market: “U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while......(read more)
Why Incyte Corporation (INCY) is in the Spotlight
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $......(read more)
11 Fastest Growing S&P 500 Companies in America
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly......(read more)
Does Incyte Corporation (INCY) Represent a Good Addition to Your Portfolio?
The market has been volatile due to elections and the potential of another Federal Reserve rate increase. Small cap stocks have been on a tear, as the......(read more)
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......(read more)
10 Most Successful Innovative Companies in The World in 2016
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these......(read more)
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......(read more)
Billionaire Leone Boosts Stake in This REIT, Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Hot Moves
It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably......(read more)
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
Is Incyte Corporation (INCY) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity......(read more)
Hedge Funds Say Just One of These Three Tuesday Movers is Worth Investing In
As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation......(read more)
Data Show Hedge Funds Like One of these Two Volatile Healthcare Stocks More than the Other
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions......(read more)
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting......(read more)
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc......(read more)
Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares......(read more)
The Baker Brothers Cut Their Position in Incyte Corporation
Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million......(read more)
Theravance Inc (THRX): Are Hedge Funds Right About This Stock?
Is Theravance Inc (NASDAQ:THRX) a good investment? At the moment, there are many indicators investors can use to analyze stocks. Some of the most under......(read more)
Veolia Environnement SA (ADR) (VE), Incyte Corporation (INCY), Cliffs Natural Resources Inc (CLF): 3 Great Downgrades You Should Know About
Analyst downgrades are a dime a dozen. They often move stocks, but few are what I would consider good calls. Historically, analysts have a tendency to......(read more)
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......(read more)
Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only......(read more)
Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?
As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of......(read more)
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......(read more)
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading......(read more)
Should You Avoid Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)?
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge......(read more)
Incyte Corporation (INCY), Pacific Biosciences of California (PACB), Astex Pharmaceuticals, Inc. (ASTX): 3 Humongous Health-Care Stocks This Week
While the overall market muddled through the past five days, some stocks were on fire. Here are three health-care stocks experiencing humongous gains......(read more)
GTx, Inc. (GTXI), Novartis AG (ADR) (NVS): This Week in Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
What Hedge Funds Think About Medivation Inc (MDVN)
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......(read more)
Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (......(read more)
Incyte Corporation (INCY), Gilead Sciences, Inc. (GILD): Pop-Worthy Data, Incyte, but Let’s See More
The phase 2 data that Incyte Corporation (NASDAQ:INCY) presented on Wednesday was downright stellar. For a subgroup of the patients, the hazard ratio......(read more)
MannKind Corporation (MNKD), Incyte Corporation (INCY): Will This Large Biotech Pop Experience Analyst Backlash?
While I do think it’s possible that MannKind Corporation (NASDAQ:MNKD)‘s inhaled insulin device, Afrezza, will be approved by the Food and......(read more)
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?
One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK......(read more)
Novartis AG (ADR) (NVS): Why Incyte Corporation (INCY) Shares Skyrocketed
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
Trending News: Incyte Corporation (INCY) Rise, Diamond Foods, Inc. (DMND) Lawsuit & Organovo Holdings Inc (ONVO)
Editor’s Note: Incyte Corporation (NASDAQ:INCY), Diamond Foods, Inc. (NASDAQ:DMND), Organovo Holdings Inc (NYSEMKT:ONVO) Incyte Rises Most in......(read more)
Novartis AG (ADR) (NVS), Amgen, Inc. (AMGN): Incyte Corporation (INCY) Jumps on Jakafi Results
Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic......(read more)
Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors......(read more)
Incyte Corporation (INCY) Earnings Cruise on Jakafi Growth
Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings......(read more)
Should You Avoid Seattle Genetics, Inc. (SGEN)?
Seattle Genetics, Inc. (NASDAQ:SGEN) was in 8 hedge funds’ portfolio at the end of the first quarter of 2013. SGEN has experienced a decrease in......(read more)
Hedge Funds Are Buying Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view. The number of bullish hedge fund......(read more)
Celgene Corporation (CELG), Alexion Pharmaceuticals, Inc. (ALXN): Is It Time To Invest In Mid & Small Cap Pharmaceuticals?
Having heard about and invested enough in large-cap pharma, I believe it is time to consider funding smaller firms in the sector. Below you will find......(read more)
Dendreon Corporation (DNDN), Bristol Myers Squibb Co. (BMY): Why Immunotherapy Stocks Could Be Set for a Big Move
If the JPMorgan Healthcare Conference in January is the mecca of all health-care events during the year, then the American Society of Clinical Oncology......(read more)
Will Pipeline Disasters Devour Eli Lilly & Co. (LLY) Stock?
Eli Lilly & Co. (NYSE:LLY) investors just can’t catch a break lately. This Big Pharma member had high hopes for replacing lost revenue from......(read more)
Infinity Pharmaceuticals Inc. (INFI): Watch This Data
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds’ portfolio at the end of December. INFI has experienced an increase in enthusiasm......(read more)
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won’t find many companies with market caps exceeding $100 billion (seven by my count). If......(read more)
